drugset / Trial / NCT00940927

Dose-response of Albuterol in Asthmatics

NCT00940927

Phase 4 Completed 81 enrolled Nemours Children's Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.

Timeline

Start
1993-07
Primary completion
1994-10
Completion
1994-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 90 ug Inhaled
Subject Salbutamol Unknown 180 ug Inhaled
Subject Salbutamol Unknown 2.5 mg Inhaled

Indications